Clinical research of remifentanil combined with midazolam as a sedative

Xilin ZhangChinese 2013

Abstract

Objective To research the clinical efficacy and safety of remifentanil combined with midazolam as a sedative.Methods Totally 400 cases of patients undergoing breast neoplasm resection were randomly divided into the local anesthesia group(100 cases) and the sedation group(300 cases),sedation group which is further divided into 3 groups with 100 cases each at random.The patients in the local anesthesia group were performed with local infiltration anesthesia with 1% lidocaine.After receiving intravenous injection of midazolam 0.04mg·kg-1 and remifentanil 0.5μg·kg-1,the three sedation groups received continuous intravenous injection of remifentanil at doses of 0.025μg·kg-1 ·min-1,0.05μg·kg-1 ·min-1,and 0.075μg·kg-1 ·min-1 respectively.The MAP,HR,SpO 2,and OAA/S sedation scores were recorded after the patients entered the operating room(T1),before local anesthesia(T2),at skin incision(T3),10 minutes after operation began(T4),and at the end of operation(T5).Results Compared with the local anesthesia group,the MAP and HR at T2,T3,T4,T5 were significantly lower and much fewer cases of hypertension occurred in the sedation group.More patients suffered from inhibition of circulation and respiration in sedation group 3 than in sedation group 1 and 2.During the operation,more patients reported pain and needed single intravenous drip of remifentanil in sedation group 1 than in sedation group 2 and 3.Conclusions It is safe and effective to use small doses of remifentanil combined with midazolam as a sedative.The optimal infusion speed of remifentanil is 0.05μg·kg-1 ·min-1.
BibTeX
@inproceedings{zhang2013clinical,
  author = {Xilin Zhang},
  title = {{Clinical research of remifentanil combined with midazolam as a sedative}},
  booktitle = {Chinese},
  year = {2013},
}

Loading related content...

Figure